Show simple item record

dc.contributor.authorBartu, Anne
dc.contributor.authorIlett, K.
dc.contributor.authorHackett, L.
dc.contributor.authorDoherty, D.
dc.contributor.authorHamilton, D.
dc.identifier.citationBartu, Anne and Ilett, Kenneth and Hackett, L Peter and Doherty, Dorota and Hamilton, Dale. 2012. Buprenorphine exposure in infants of opioid-dependent mothers at birth. Australian and New Zealand Journal of Obstetrics and Gynaecology. 52 (4): pp. 342-347.

Background: Buprenorphine, a partial opioid agonist used in treating opioid dependence, is not approved in Australia for use in pregnancy. Nevertheless, many pregnant women choose to remain on the drug. Aim: To investigate cord/maternal transfer ratios for buprenorphine and norbuprenorphine in women at delivery. Methods: Maternal and cord serum samples were collected from 10 maternal-infant pairs at delivery. Drug concentrations were measured by liquid chromatography-tandem mass spectrometry. Maternal and infant demographic information was collected. Linear regression was used to assess the relationship between maternal and cord measurements. Results: Median (interquartile range) maternal age was 27 (23.8–32) years, with 90% of the women on buprenorphine before pregnancy. Median infant birthweight was 3148 (3088–3545) g and 60% of infants had neonatal abstinence requiring admission to a neonatal intensive care unit for a median of 8.5 (2.5–16.3) days. Median maternal buprenorphine daily dose was 8.5 mg (range 1–28 mg). Mean (95% confidence interval) cord serum concentrations of buprenorphine and norbuprenorphine were 0.4 (0.3–0.5) μg/L and 1.2 (0.9–1.4) μg/L, respectively. Mean maternal concentrations of buprenorphine and norbuprenorphine were 1.0 (0.6–1.4) μg/L and 1.2 (0.9–1.4) μg/L, respectively. Mean cord/maternal ratios were 0.43 (0.36–0.5) for buprenorphine and 0.53 (0.43–0.63) for norbuprenorphine. Maternal buprenorphine and norbuprenorphine concentrations and ratio of buprenorphine/norbuprenorphine explained 85.7, 69.6 and 94.4%, respectively, of variation in the corresponding cord concentrations. Conclusion: Usual therapeutic doses of buprenorphine administered to pregnant women resulted in low concentrations of buprenorphine and norbuprenorphine in maternal serum and a low transfer to the fetal circulation (cord plasma) at birth.

dc.publisherWiley-Blackwell Publishing Asia
dc.subjectinfant exposure at delivery
dc.subjectplacental transfer
dc.titleBuprenorphine exposure in infants of opioid-dependent mothers at birth
dc.typeJournal Article
dcterms.source.titleAustralian and New Zealand Journal of Obstetrics and Gynaecology
curtin.accessStatusFulltext not available

Files in this item


This item appears in the following Collection(s)

Show simple item record